Singapore, Oct. 10 -- Researchers from Australia's University of Queensland (UQ) and University of Cambridge in the UK have developed a platform for human cells powered by artificial intelligence (AI) that could aid the development of therapeutics and personalised treatments for cancer patients.

The platform - called DNAscent - combines AI software with nanopore DNA sequencing to study how DNA is copied in cancer cells, and what happens when that process is disrupted during chemotherapy.

UQ Frazer Institutesenior research fellowDr Mathew Jonessaid that DNAscent will help researchers identify biomarkers that can better predict how tumours will respond to chemotherapies.

DNAscent is a method to more accurately measure DNA replication str...